These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 1880254)

  • 1. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
    Kanzler MH; Gorsulowsky D
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):509. PubMed ID: 1564165
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
    Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
    Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H; Heickendorff L; Søgaard H
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
    Kürkçüoğlu N; Oz G
    J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
    Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
    Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H; Søgaard H; Heickendorff L
    Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis.
    Hayasaka A; Koch J; Schuppan D; Maddrey WC; Hahn EG
    J Hepatol; 1991 Nov; 13(3):328-38. PubMed ID: 1725528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Boffa MJ; Smith A; Chalmers RJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
    [No Abstract]   [Full Text] [Related]  

  • 18. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
    Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
    Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
    Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
    J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.